Last €74.71 EUR
Change Today -1.81 / -2.37%
Volume 65.8K
MOR On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 10:41 AM 10/2/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - MORPHOSYS AG (MOR)

Morphosys AG to Report Nine Months, 2014 on Nov 07, 2014
CapIQ 11/07/2014 5:00 AM ET
Morphosys AG to Report First Half, 2014 on Jul 28, 2014
CapIQ 11/07/2014 5:00 AM ET
Morphosys AG to Report Q1, 2014 on Apr 29, 2014
CapIQ 11/07/2014 5:00 AM ET

2013 revenues at Morphosys AG totaled €78.0M EUR, while annual earnings equaled €0.30 per share.

Quarterly Earnings & Estimates - MORPHOSYS AG (MOR)

Chart not available

Morphosys AG's Quarterly Earnings

Morphosys AG reported 2nd quarter 2014 losses of €0.02 per share on 07/30/2014.

Annual Earnings & Estimates - MORPHOSYS AG (MOR)

Actuals vs. Estimates for MORPHOSYS AG MOR

Morphosys AG's Annual Earnings

Morphosys AG reported annual 2013 earnings of €0.30 per share on 03/2/2014.

Quarterly Revenues - MORPHOSYS AG (MOR)

Actuals vs. Estimates for MORPHOSYS AG MOR

Morphosys AG's Quarterly Revenues

Morphosys AG had 2nd quarter 2014 revenues of €14.6M EUR. This missed the €14.7M EUR consensus estimate of the 2 analysts following the company. This was -53.4% below the prior year's 2nd quarter results.

Annual Revenues - MORPHOSYS AG (MOR)

Actuals vs. Estimates for MORPHOSYS AG MOR

Morphosys AG's Annual Revenues

Morphosys AG had revenues for the full year 2013 of €78.0M EUR. This was 12.1% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €74.52 EUR -2.00

MOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ablynx NV €8.34 EUR -0.137
Dyax Corp $9.94 USD -0.17
Genmab A/S kr251.30 DKK +0.20
ImmunoGen Inc $10.46 USD +0.0099
Intrexon Corp $17.50 USD -0.17
View Industry Companies
 

Industry Analysis

MOR

Industry Average

Valuation MOR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.7x
Price/Book 5.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 25.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.